TY - JOUR
T1 - The protective effect of alpha-tocopherol against dichromate-induced renal tight junction damage is mediated via ERK1/2
AU - Arreola-Mendoza, Laura
AU - Del Razo, Luz M.
AU - Mendoza-Garrido, Maria E.
AU - Martin, Dolores
AU - Namorado, Maria C.
AU - Calderon-Salinas, Jose V.
AU - Reyes, Jose L.
N1 - Funding Information:
This study was supported by grants from the National Research Council of Mexico (CONACYT No. 51755 and G34511-M ). Laura Arreola-Mendoza is recipient of a postgraduate fellowship from CONACYT (170204).
PY - 2009/12/15
Y1 - 2009/12/15
N2 - Renal tight junctions (TJ) play a central role in modulating the paracellular pathway. We examined the function, quantity and distribution of TJ proteins: occludin and claudin-2 (cln-2), on proximal tubule in a model of acute renal failure (ARF) associated with oxidative damage. Since ERK1/2-p modulates TJ integrity, we studied their participation in dichromate (Cr6+) toxicity. We evaluated whether co-administration of the antioxidant alpha-tocopherol (α-TOC) prevents Cr6+ toxicity in TJ. Female Wistar rats received potassium dichromate 15 mg/kg, sc (5.3 mg/kg of Cr6+) single dose, with or without α-TOC (125 mg/kg, po, daily). Two and 7 days after Cr6+treatment, oxidative damage was assessed by renal lipid peroxidation (LPO), proximal function was estimated by sodium and glucose fractional excretions. Occludin, cln-2, and ERK1/2-p were detected by immunofluorescence and Western blot. ARF induced by Cr6+ provoked augment in the sodium and glucose urinary looses, increases in occludin quantity (6.6- and 15-fold on days 2 and 7, respectively) and the mislocation of cln-2. Electrophoresis migration showed a higher molecular weight band only in the Cr6+-administered groups, suggesting occludin hyperphosphorylation. α-TOC treatment diminished the LPO, improved tubular function, and preserved TJ location and expression. In summary, we show disruption of occludin and cln-2 in ARF induced by Cr6+-intoxication. This study provides evidence of the beneficial effect of α-TOC on TJ structure and function undergoing oxidative damage, and we suggest the participation of ERK1/2 in the mechanisms leading to protection by the antioxidant.
AB - Renal tight junctions (TJ) play a central role in modulating the paracellular pathway. We examined the function, quantity and distribution of TJ proteins: occludin and claudin-2 (cln-2), on proximal tubule in a model of acute renal failure (ARF) associated with oxidative damage. Since ERK1/2-p modulates TJ integrity, we studied their participation in dichromate (Cr6+) toxicity. We evaluated whether co-administration of the antioxidant alpha-tocopherol (α-TOC) prevents Cr6+ toxicity in TJ. Female Wistar rats received potassium dichromate 15 mg/kg, sc (5.3 mg/kg of Cr6+) single dose, with or without α-TOC (125 mg/kg, po, daily). Two and 7 days after Cr6+treatment, oxidative damage was assessed by renal lipid peroxidation (LPO), proximal function was estimated by sodium and glucose fractional excretions. Occludin, cln-2, and ERK1/2-p were detected by immunofluorescence and Western blot. ARF induced by Cr6+ provoked augment in the sodium and glucose urinary looses, increases in occludin quantity (6.6- and 15-fold on days 2 and 7, respectively) and the mislocation of cln-2. Electrophoresis migration showed a higher molecular weight band only in the Cr6+-administered groups, suggesting occludin hyperphosphorylation. α-TOC treatment diminished the LPO, improved tubular function, and preserved TJ location and expression. In summary, we show disruption of occludin and cln-2 in ARF induced by Cr6+-intoxication. This study provides evidence of the beneficial effect of α-TOC on TJ structure and function undergoing oxidative damage, and we suggest the participation of ERK1/2 in the mechanisms leading to protection by the antioxidant.
KW - Acute renal failure
KW - Mitogen activated protein kinases
KW - Oxidative stress
KW - Phosphorylation
KW - Tight junctions
UR - http://www.scopus.com/inward/record.url?scp=70449535527&partnerID=8YFLogxK
U2 - 10.1016/j.toxlet.2009.09.011
DO - 10.1016/j.toxlet.2009.09.011
M3 - Artículo
SN - 0378-4274
VL - 191
SP - 279
EP - 288
JO - Toxicology Letters
JF - Toxicology Letters
IS - 2-3
ER -